Zaw Thant lwin*, Lim Su Kwan, Clare Silverwood
Venous thromboembolism (VTE) prophylaxis is an important management plan for every patient admitted to the Acute Medical Unit in a hospital. Pulmonary embolism remains as the leading cause of preventable in-hospital death. Bleeding risk and possible contraindication to antithrombotic agents must be assessed before instituting VTE thromboprophylaxis. • Based on national and international thromboprophylaxis guidelines, only 40-50% of medical patients received VTE prophylaxis while 60-75% of surgical patients received VTE prophylaxis. The 2018 National Institute of Clinical Excellence (NICE) guidelines recommend to prescribe VTE prophylaxis to all admitted patients who need it within 14hours of admission. When the assessment of risk favours the use of thromboprophylaxis, low molecular weight heparin or fondaparinux should be administered. Method: Collecting preliminary data, intervention, data collection, reviews of data, meetings with medical staff and ongoing improvement made. Duration: August 2018 to July 2019, across a year span. 5 patients data are randomly collected every week and Microsoft excel software is used to generate the percentage.
